Rademikibart - CAS 2648260-80-2

Rademikibart (CBP-201) is a humanised monoclonal antibody targeting IL-4Rα (KD = 20.7 pM) that does not interact with IL-4Rα from other species. Rademikibart inhibits IL-4 and IL-13-mediated STAT6 signalling pathways, TF-1 cell proliferation, and TARC production in PBMCs, making it useful for studying Th2-type inflammatory diseases.

IL Receptor, Interleukin

Immunology/Inflammation

2648260-80-2

0.983

-20°C

Ice Packs

Inhibitory Antibodies